Relationship of Initial Blood Glucose Levels to Atypical Angina in Individuals with Coronary Artery Disease
-
By
-
Zhen Li
-
Xu-ru Li
-
Zheng Huang
-
Xiao-lin Ma
-
Jing-shui Zhang
-
Cun-ming Fang
-
Tian-kui Gong
-
Wen-long Ding
-
Rui Tao
-
Xue-Jun Hu
-
Zu-fei Wu
-
March 11, 2026
-
Clinical Scorecard: Relationship of Initial Blood Glucose Levels to Atypical Angina in Individuals with Coronary Artery Disease
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Hyperglycemia associated with coronary microvascular dysfunction and stent restenosis, particularly in atypical angina. |
| Target Population | |
| Care Setting | |
Key Highlights
- Atypical angina accounts for 20% to 45% of cases in stable coronary artery disease.
- Hyperglycemia may drive adverse outcomes in acute coronary syndrome.
- Timely identification of atypical angina is critical for effective management.
- Patients with atypical symptoms are often overlooked, leading to diagnostic delays.
- Distinct clinical profiles exist between MINOCA and MI-CAD patients.
- Monitoring blood glucose levels is essential in patients with atypical angina.
Guideline-Based Recommendations
Diagnosis
Management
- Implement standardized dual antiplatelet therapy and guideline-directed medical therapy at discharge.
- Consider specific strategies for managing blood glucose levels in patients with atypical angina.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients received dual antiplatelet therapy and lipid-lowering therapy (e.g., atorvastatin 80 mg) upon discharge.
Clinical Best Practices
- Maintain high vigilance for atypical angina presentations.
- Educate non-cardiology physicians on recognizing atypical symptoms of coronary artery disease.
- Ensure timely intervention for patients presenting with atypical angina.
- Encourage interdisciplinary collaboration to improve recognition and management of atypical angina.
References
